The efficacy and safety of PSD503 (phenylephrine 20%, w/w) for topical application in women with stress urinary incontinence. A phase II, multicentre, double-blind, placebo controlled, 2-way cross over study

Phase Ii ◽

Topical Application ◽

Efficacy And Safety ◽

Double Blind ◽

Re: The Efficacy and Safety of PSD503 (Phenylephrine 20%, w/w) for Topical Application in Women with Stress Urinary Incontinence. A Phase II, Multicentre, Double-Blind, Placebo Controlled, 2-Way Cross Over Study

The Journal of Urology ◽

10.1016/j.juro.2012.08.157 ◽

2012 ◽

Vol 188 (6) ◽

pp. 2301-2302

Author(s):

Alan J. Wein

Keyword(s):

Urinary Incontinence ◽

Phase Ii ◽

Topical Application ◽

Efficacy And Safety ◽

Double Blind ◽

The Efficacy and Safety of PSD503 (phenylephrine 20% w/w) for Topical Application in Women with Stress Urinary Incontinence. A Phase II, Multi-Centre, Double-Blind, Placebo-Controlled, Cross-Over Study

UroToday International Journal ◽

10.3834/uij.1939-4810.2008.06.39 ◽

2008 ◽

Author(s):

Linda Cardozo

Keyword(s):

Urinary Incontinence ◽

Phase Ii ◽

Topical Application ◽

Efficacy And Safety ◽

Double Blind ◽

A phase II, multi-centre, double-blind, placebo-controlled, 2-way cross-over study to evaluate efficacy, plasma concentrations and safety of 0.25 mL of 20 % w/w PSD503 for topical application in female volunteer patients with stress urinary incontinence

http://isrctn.org/> ◽

10.1186/isrctn39853232 ◽

2012 ◽

Author(s):

Sheryl Caswell

Keyword(s):

Urinary Incontinence ◽

Phase Ii ◽

Topical Application ◽

Plasma Concentrations ◽

Female Volunteer ◽

Double Blind ◽

Efficacy and safety of the noradrenaline reuptake inhibitor, TAS‐303, in women with stress urinary incontinence: Results of a double‐blind, randomized, placebo‐controlled, early phase II trial

International Journal of Urology ◽

10.1111/iju.14411 ◽

2020 ◽

Author(s):

Satoru Takahashi ◽

Kumiko Kato ◽

Mineo Takei ◽

Osamu Yokoyama ◽

Momokazu Gotoh

Keyword(s):

Urinary Incontinence ◽

Phase Ii ◽

Reuptake Inhibitor ◽

Early Phase ◽

Phase Ii Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study

International Urogynecology Journal ◽

10.1007/bf02001083 ◽

1998 ◽

Vol 9 (3) ◽

pp. 145-150 ◽

Cited By ~ 28

Author(s):

E. H. J. Weil ◽

P. H. A. Eerdmans ◽

G. A. Dijkman ◽

K. Tamussino ◽

J. Feyereisl ◽

...

Keyword(s):

Urinary Incontinence ◽

Phase Ii ◽

Phase Ii Study ◽

Dose Finding ◽

Double Blind ◽

Double Blind Placebo ◽

Moderate Stress

A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study to evaluate the efficacy and safety of VT‐1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail

British Journal of Dermatology ◽

10.1111/bjd.19224 ◽

2020 ◽

Cited By ~ 1

Author(s):

B. Elewski ◽

S. Brand ◽

T. Degenhardt ◽

S. Curelop ◽

R. Pollak ◽

...

Keyword(s):

Phase Ii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Ranging

Efficacy and Safety of Lebrikizumab in Severe Uncontrolled Asthma: Results from the Lute and Verse Phase II Randomized, Double-Blind, Placebo-Controlled Trials

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2013.12.1064 ◽

2014 ◽

Vol 133 (2) ◽

pp. AB402 ◽

Cited By ~ 13

Author(s):

Nicola A. Hanania ◽

Michael J. Noonan ◽

Jonathan Corren ◽

Phillip Korenblat ◽

Yanan Zheng ◽

...

Keyword(s):

Phase Ii ◽

Controlled Trials ◽

Efficacy And Safety ◽

Uncontrolled Asthma ◽

Double Blind ◽

522 EFFICACY AND SAFETY OF OXYBUTYNIN TOPICAL GEL (84 MG OR 56 MG/DAY) IN PATIENTS WITH URGENCY AND/OR MIXED URINARY INCONTINENCE: RESULTS OF A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY

The Journal of Urology ◽

10.1016/j.juro.2012.02.594 ◽

2012 ◽

Vol 187 (4S) ◽

Cited By ~ 1

Author(s):

Evan Goldfischer ◽

Peter Sand ◽

Jill Peters-Gee

Keyword(s):

Urinary Incontinence ◽

Mixed Urinary Incontinence ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Topical Gel

Stress urinary incontinence in postmenopausal women treated with oral estrogen (estriol) and an alpha-adrenoceptor-stimulating agent (phenylpropanolamine): A randomized double-blind placebo-controlled study

International Urogynecology Journal ◽

10.1007/bf00600025 ◽

1990 ◽

Vol 1 (2) ◽

pp. 74-79 ◽

Cited By ~ 39

Author(s):

S. Walter ◽

B. Kj�rgaard ◽

G. Lose ◽

J. T. Andersen ◽

L. Heisterberg ◽

...

Keyword(s):

Urinary Incontinence ◽

Postmenopausal Women ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Alpha Adrenoceptor ◽

Oral Estrogen

Efficacy and Safety of Additional 200-mg Dose of Celecoxib in Adult Patients With Postoperative Pain Following Extraction of Impacted Third Mandibular Molar: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Japan

Clinical Therapeutics ◽

10.1016/j.clinthera.2012.01.004 ◽

2012 ◽

Vol 34 (2) ◽

pp. 314-328 ◽

Cited By ~ 10

Author(s):

Ken‘ichi Saito ◽

Akihiro Kaneko ◽

Katsuyuki Machii ◽

Hiroyoshi Ohta ◽

Masayuki Ohkura ◽

...

Keyword(s):

Postoperative Pain ◽

Phase Ii ◽

Phase Ii Study ◽

Adult Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Mandibular Molar